p38 MAP kinase inhibitors (Merck & Co)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namep38 MAP kinase inhibitors (Merck & Co)
Drug Alias NameL-167307MK-0913L-790070
ClassificationSmall molecules
Mechanisms of ActionImmunosuppressantsP38 α mitogen-activated protein kinase inhibitors
TargetsP38 α mitogen-activated protein kinase
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMerck Research Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck Research Laboratories
Active IndicationsN/A
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A